Clinical Trial Update: The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin [Phase 4]

View source ↗

Summary

Phase 4 trial update on the efficacy and safety of triple therapy telmisartan/amlodipine/rosuvastatin for hypertension and dyslipidemias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Hypertension

Drugs mentioned

• Telmisartan/Amlodipine/Rosuvastatin

Snippet

Sponsor: Hyo-Soo Kim | Conditions: Hypertension, Dyslipidemias | Phase 4 | Status: COMPLETED